Rare Neoplastic Syndrome
1 clinical trials · Condition
◉ Watch Rare Neoplastic Syndrome
| Record | Firm | Date |
|---|---|---|
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
Track Rare Neoplastic Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.